{"id":2426,"date":"2018-11-19T11:25:08","date_gmt":"2018-11-19T11:25:08","guid":{"rendered":"https:\/\/www.sygnaturediscovery.com\/journal-paper\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\/"},"modified":"2018-11-19T11:25:08","modified_gmt":"2018-11-19T11:25:08","slug":"discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma","status":"publish","type":"journal-paper","link":"https:\/\/www.sygnaturediscovery.com\/fr\/journal-paper\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\/","title":{"rendered":"Narrow Spectrum Kinase Inhibitors: Treating COPD and Steroid-Resistant Asthma"},"content":{"rendered":"

Stuart T. Onions, Kazuhiro Ito, Catherine E. Charron, Richard J. Brown, Marie Colucci, Fritz Frickel, George Hardy, Kevin Joly, John King-Underwood, Yasuo Kizawa, Ian Knowles, P. John Murray, Andrew Novak, Anjna Rani, Garth Rapeport, Alun Smith, Peter Strong, David M. Taddei, and Jonathan G. Williams<\/p>\n

Abstract<\/strong><\/p>\n

The discovery of a novel series of therapeutic agents that has been designed and optimized for treating chronic obstructive pulmonary disease is reported. The pharmacological strategy was based on the identification of compounds that inhibit a defined subset of kinase enzymes modulating inflammatory processes that would be effective against steroid refractory disease and exhibit a sustained duration of action after inhaled delivery.<\/p>\n

Ref:<\/strong> J. Med. Chem., 59, (5), 1727 – 1746<\/p>\n","protected":false},"excerpt":{"rendered":"

Experience therapeutic potential with narrow spectrum kinase inhibitors for COPD and steroid-resistant asthma.<\/p>\n","protected":false},"featured_media":0,"template":"","category":[1],"resource_tag":[],"class_list":["post-2426","journal-paper","type-journal-paper","status-publish","hentry","category-uncategorized"],"acf":[],"yoast_head":"\nDiscovery of Narrow Spectrum Kinase Inhibitors<\/title>\n<meta name=\"description\" content=\"Therapeutic potential with narrow spectrum kinase inhibitors for COPD and steroid-resistant asthma. Explore ground-breaking advancements.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sygnaturediscovery.com\/fr\/journal-paper\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Discovery of Narrow Spectrum Kinase Inhibitors\" \/>\n<meta property=\"og:description\" content=\"Therapeutic potential with narrow spectrum kinase inhibitors for COPD and steroid-resistant asthma. Explore ground-breaking advancements.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sygnaturediscovery.com\/fr\/journal-paper\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\/\" \/>\n<meta property=\"og:site_name\" content=\"Sygnature\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/sygnature-hit-to-lead-team-collaboration-scaled.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/journal-paper\\\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/journal-paper\\\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\\\/\",\"name\":\"Discovery of Narrow Spectrum Kinase Inhibitors\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\"},\"datePublished\":\"2018-11-19T11:25:08+00:00\",\"description\":\"Therapeutic potential with narrow spectrum kinase inhibitors for COPD and steroid-resistant asthma. Explore ground-breaking advancements.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/journal-paper\\\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/journal-paper\\\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/journal-paper\\\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/page-daccueil\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Narrow Spectrum Kinase Inhibitors: Treating COPD and Steroid-Resistant Asthma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"name\":\"Sygnature Discovery\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\"},\"alternateName\":\"Sygnature\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\",\"name\":\"Sygnature Discovery\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Sygnature Discovery\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Discovery of Narrow Spectrum Kinase Inhibitors","description":"Therapeutic potential with narrow spectrum kinase inhibitors for COPD and steroid-resistant asthma. Explore ground-breaking advancements.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sygnaturediscovery.com\/fr\/journal-paper\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\/","og_locale":"fr_CA","og_type":"article","og_title":"Discovery of Narrow Spectrum Kinase Inhibitors","og_description":"Therapeutic potential with narrow spectrum kinase inhibitors for COPD and steroid-resistant asthma. Explore ground-breaking advancements.","og_url":"https:\/\/www.sygnaturediscovery.com\/fr\/journal-paper\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\/","og_site_name":"Sygnature","og_image":[{"width":2560,"height":1707,"url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/sygnature-hit-to-lead-team-collaboration-scaled.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimation du temps de lecture":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/journal-paper\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\/","url":"https:\/\/www.sygnaturediscovery.com\/fr\/journal-paper\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\/","name":"Discovery of Narrow Spectrum Kinase Inhibitors","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website"},"datePublished":"2018-11-19T11:25:08+00:00","description":"Therapeutic potential with narrow spectrum kinase inhibitors for COPD and steroid-resistant asthma. Explore ground-breaking advancements.","breadcrumb":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/journal-paper\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sygnaturediscovery.com\/fr\/journal-paper\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/journal-paper\/discovery-of-narrow-spectrum-kinase-inhibitors-new-therapeutic-agents-for-the-treatment-of-copd-and-steroid-resistant-asthma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sygnaturediscovery.com\/fr\/page-daccueil\/"},{"@type":"ListItem","position":2,"name":"Narrow Spectrum Kinase Inhibitors: Treating COPD and Steroid-Resistant Asthma"}]},{"@type":"WebSite","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","name":"Sygnature Discovery","description":"","publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"alternateName":"Sygnature","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization","name":"Sygnature Discovery","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","width":1,"height":1,"caption":"Sygnature Discovery"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/journal-paper\/2426","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/journal-paper"}],"about":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/types\/journal-paper"}],"version-history":[{"count":0,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/journal-paper\/2426\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media?parent=2426"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/category?post=2426"},{"taxonomy":"resource_tag","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/resource_tag?post=2426"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}